Skip to main content

and
  1. No Access

    Article

    The landscape of T cell antigens for cancer immunotherapy

    The remarkable capacity of immunotherapies to induce durable regression in some patients with metastatic cancer relies heavily on T cell recognition of tumor-presented antigens. As checkpoint-blockade therapy ...

    Aviyah Peri, Nadja Salomon, Yochai Wolf, Sebastian Kreiter, Mustafa Diken in Nature Cancer (2023)

  2. No Access

    Article

    A complex epigenome-splicing crosstalk governs epithelial-to-mesenchymal transition in metastasis and brain development

    Epithelial-to-mesenchymal transition (EMT) renders epithelial cells migratory properties. While epigenetic and splicing changes have been implicated in EMT, the mechanisms governing their crosstalk remain poor...

    Sanjeeb Kumar Sahu, Eneritz Agirre, Mohammed Inayatullah in Nature Cell Biology (2022)

  3. Article

    Open Access

    Immunomic, genomic and transcriptomic characterization of CT26 colorectal carcinoma

    Tumor models are critical for our understanding of cancer and the development of cancer therapeutics. Here, we present an integrated map of the genome, transcriptome and immunome of an epithelial mouse tumor, ...

    John C Castle, Martin Loewer, Sebastian Boegel, Jos de Graaf in BMC Genomics (2014)

  4. Article

    Open Access

    Tetracycline-controlled transgene activation using the ROSA26-iM2-GFP knock-in mouse strain permits GFP monitoring of DOX-regulated transgene-expression

    Conditional gene activation is an efficient strategy for studying gene function in genetically modified animals. Among the presently available gene switches, the tetracycline-regulated system has attracted con...

    Simone Wörtge, Leonid Eshkind, Nina Cabezas-Wallscheid in BMC Developmental Biology (2010)